Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis
暂无分享,去创建一个
S. Siddharth | D. Sharma | C. Sears | Shaoguang Wu | H. Gatla | S. Parida | K. Gabrielson | Guannan Wang | Brian H. Ladle | Kathleen Gabrielson
[1] D. Sharma,et al. The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful! , 2023, Gut microbes.
[2] S. Siddharth,et al. Concomitant analyses of intratumoral microbiota and genomic features reveal distinct racial differences in breast cancer , 2023, npj Breast Cancer.
[3] Ling Yang,et al. The critical role of gut microbiota in obesity , 2022, Frontiers in Endocrinology.
[4] Xue-zhen Zhu,et al. Gut microbiota accelerates obesity in peri-/post-menopausal women via Bacteroides fragilis and acetic acid , 2022, International Journal of Obesity.
[5] I. Barman,et al. Label-Free Vibrational and Quantitative Phase Microscopy Reveals Remarkable Pathogen-Induced Morphomolecular Divergence in Tumor-Derived Cells. , 2022, ACS sensors.
[6] B. Lutz,et al. The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism , 2022, Frontiers in Cellular Neuroscience.
[7] Yue Zhang,et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer , 2022, Cell.
[8] Fan Yang,et al. Effects of Konjaku Flour on the Gut Microbiota of Obese Patients , 2022, Frontiers in Cellular and Infection Microbiology.
[9] Chenguang Wang,et al. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression , 2021, eLife.
[10] Liaoliao Dong,et al. Neutrophils in cancer carcinogenesis and metastasis , 2021, Journal of Hematology & Oncology.
[11] Tejaswini Appidi,et al. The role played by bacterial infections in the onset and metastasis of cancer , 2021, Current research in microbial sciences.
[12] I. Barman,et al. Vibrational spectroscopy for decoding cancer microbiota interactions: Current evidence and future perspective. , 2021, Seminars in cancer biology.
[13] J. Raes,et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice , 2021, Gut.
[14] Ezanee Azlina Mohamad Hanif,et al. Pathogens and Carcinogenesis: A Review , 2021, Biology.
[15] R. Ganju,et al. Lipopolysaccharide from the commensal microbiota of the breast enhances cancer growth: role of S100A7 and TLR4 , 2021, Molecular oncology.
[16] C. Eng,et al. Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer , 2021, Genome medicine.
[17] Xuelian Song,et al. The potential role and status of IL-17 family cytokines in breast cancer. , 2021, International immunopharmacology.
[18] K. Konstantopoulos,et al. A pro-carcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates Notch and βcatenin axes. , 2021, Cancer discovery.
[19] K. Varley,et al. The lingering mysteries of metastatic recurrence in breast cancer , 2020, British journal of cancer.
[20] D. Sharma,et al. The Microbiome and Cancer: Creating Friendly Neighborhoods and Removing the Foes Within , 2020, Cancer Research.
[21] Aaron W. Miller,et al. The development of metabolic endotoxemia is dependent on the type of sweetener and the presence of saturated fat in the diet , 2020, Gut microbes.
[22] J. Vogel,et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression , 2020, Nature Communications.
[23] Noam Shental,et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.
[24] Tamara L. Kinzer-Ursem,et al. The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites , 2020, Cancers.
[25] D. Sharma,et al. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights , 2020, Cells.
[26] W. Demark-Wahnefried,et al. Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. , 2020, Journal of the Academy of Nutrition and Dietetics.
[27] E. Di Carlo. Decoding the Role of Interleukin-30 in the Crosstalk between Cancer and Myeloid Cells , 2020, Cells.
[28] J. Ferlay,et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. , 2019, The Lancet. Global health.
[29] D. Sharma,et al. The Microbiome–Estrogen Connection and Breast Cancer Risk , 2019, Cells.
[30] Xiaoxia Li,et al. The role of interleukin-17 in tumor development and progression , 2019, The Journal of experimental medicine.
[31] K. Gee,et al. IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer , 2019, Front. Oncol..
[32] A. Nawaz,et al. Linkage of CD8+ T cell exhaustion with high-fat diet-induced tumourigenesis , 2019, Scientific Reports.
[33] D. Sharma,et al. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer , 2019, Biochimica et biophysica acta. Reviews on cancer.
[34] M. Sang,et al. Effect of gastrointestinal microbiome and its diversity on the expression of tumor-infiltrating lymphocytes in breast cancer , 2019, Oncology letters.
[35] F. Antonicelli,et al. The Interleukin-17 Family of Cytokines in Breast Cancer , 2018, International journal of molecular sciences.
[36] William H. Bisson,et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin , 2018, Nature Medicine.
[37] C. Donati,et al. Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions , 2018, Scientific Reports.
[38] J. Suttles,et al. Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development. , 2018, Cell metabolism.
[39] Junjie Yang,et al. Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy , 2018, Front. Oncol..
[40] Qibin Li,et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome , 2018, Microbiome.
[41] Mimi Y. Kim,et al. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[42] Huijue Jia,et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.
[43] Eva M. Schmelz,et al. N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro , 2017, bioRxiv.
[44] F. Antonicelli,et al. Interleukin 17 in the tumor microenvironment: A potent target for anticancer immunotherapy? , 2017 .
[45] D. Ribatti,et al. Interleukin-30 Promotes Breast Cancer Growth and Progression. , 2016, Cancer research.
[46] Krishna R. Kalari,et al. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease , 2016, Scientific Reports.
[47] G. Gloor,et al. The Microbiota of Breast Tissue and Its Association with Breast Cancer , 2016, Applied and Environmental Microbiology.
[48] S. Love,et al. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors , 2016, Scientific Reports.
[49] F. Groppo,et al. Correlation between body mass index and faecal microbiota from children. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[50] X. Zhang,et al. Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease , 2015, Mediators of inflammation.
[51] Catherine C. Park,et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[52] D. Tiezzi,et al. IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. , 2015, Cancer research.
[53] J. Eliaou,et al. Abstract 3171: IL-25/IL-17E does not induce breast tumor cell apoptosis and both IL-17A and IL-25/IL-17E contribute to breast cancer survival and proliferation associated with generation of pro-oncogenic low molecular forms of cyclin E , 2015 .
[54] M. Chew,et al. Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model , 2015, BMC Cancer.
[55] J. Ward,et al. Gut bacteria require neutrophils to promote mammary tumorigenesis , 2015, Oncotarget.
[56] O. De Wever,et al. The Quorum Sensing Peptides PhrG, CSP and EDF Promote Angiogenesis and Invasion of Breast Cancer Cells In Vitro , 2015, PloS one.
[57] B. Hennessy,et al. Obesity Correlation With Metastases Development and Response to First-Line Metastatic Chemotherapy in Breast Cancer , 2015, Clinical Medicine Insights. Oncology.
[58] I. Arts,et al. The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study , 2014, International Journal of Obesity.
[59] H. Gruber,et al. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches , 2014, BMC Cancer.
[60] J. Shamonki,et al. Microbial Dysbiosis Is Associated with Human Breast Cancer , 2014, PloS one.
[61] J. Eliaou,et al. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2 , 2013, Scientific Reports.
[62] D. Yahav,et al. Gut bacterial microbiota and obesity. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[63] Y. Yamaoka,et al. Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils , 2011, Journal of gastroenterology and hepatology.
[64] C. Sears,et al. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis , 2010, Cell cycle.
[65] D. Redelman,et al. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.
[66] Jide Wang,et al. Helicobacter pylori Infection Induces Oxidative Stress and Programmed Cell Death in Human Gastric Epithelial Cells , 2007, Infection and Immunity.
[67] A. Tzianabos,et al. Diversity of the Metalloprotease Toxin Produced by Enterotoxigenic Bacteroides fragilis , 2002, Infection and Immunity.
[68] E. Mortani,et al. Intestinal Microflora as an Alternative Metabolic Source of Estrogens in Women with Uterine Leiomyoma and Breast Cancer , 1990 .
[69] M. Ewertz,et al. Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.